Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

WAVE Life Sciences Price to Book Ratio 2014-2024 | WVE

Historical price to book ratio values for WAVE Life Sciences (WVE) over the last 10 years. The current price to book ratio for WAVE Life Sciences as of October 16, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
  
WAVE Life Sciences Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-10-16 14.90 0.00
2024-06-30 4.99 $-0.03 -175.70
2024-03-31 6.17 $0.21 29.72
2023-12-31 5.05 $0.33 15.18
2023-09-30 5.75 $-0.41 -14.06
2023-06-30 3.64 $-0.52 -6.94
2023-03-31 4.33 $-0.35 -12.24
2022-12-31 7.00 $-0.52 -13.50
2022-09-30 3.61 $-0.05 -69.42
2022-06-30 3.25 $0.36 9.11
2022-03-31 2.00 $-0.00 -2222.22
2021-12-31 3.14 $0.54 5.78
2021-09-30 4.90 $0.58 8.52
2021-06-30 6.66 $0.43 15.42
2021-03-31 5.61 $1.06 5.29
2020-12-31 7.87 $1.70 4.64
2020-09-30 8.49 $2.22 3.83
2020-06-30 10.41 $-0.13 -82.88
2020-03-31 9.37 $0.60 15.54
2019-12-31 8.02 $1.86 4.32
2019-09-30 20.53 $3.35 6.13
2019-06-30 26.09 $4.68 5.58
2019-03-31 38.85 $5.98 6.50
2018-12-31 42.04 $2.49 16.89
2018-09-30 50.00 $3.89 12.85
2018-06-30 38.25 $5.02 7.61
2018-03-31 40.10 $4.21 9.52
2017-12-31 35.10 $5.30 6.62
2017-09-30 21.75 $6.26 3.48
2017-06-30 18.60 $7.10 2.62
2017-03-31 27.50 $5.31 5.18
2016-12-31 26.15 $6.07 4.31
2016-09-30 32.47 $6.77 4.79
2016-06-30 20.69 $7.43 2.78
2016-03-31 13.88 $7.16 1.94
2015-12-31 15.95 $7.49 2.13
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.859B $0.113B
WAVE Life Sciences Pte. Ltd. is a preclinical biopharmaceutical company. It designs, develops and commercializes nucleic acid therapeutic candidates for Huntington's disease, Duchenne muscular dystrophy and inflammatory bowel disease. Huntington's disease, the Company has programs targeting HTT SNP-1 and HTT SNP-2; DMD, targeting Exon 51 and in IBD, it is targeting SMAD7. The Company has late-stage discovery programs in epidermolysis bullosa simplex, in which it is targeting KRT14 SNP-1 and KRT14 SNP-2 and in DMD, it is focused on an additional DMD target, Activin Receptor type IIb. WAVE Life Sciences Pte. Ltd. is based in Singapore.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $172.821B 17.29
Vertex Pharmaceuticals (VRTX) United States $125.760B 0.00
Regeneron Pharmaceuticals (REGN) United States $111.112B 26.24
Bristol Myers Squibb (BMY) United States $108.202B 38.96
Gilead Sciences (GILD) United States $108.003B 18.46
CSL (CSLLY) Australia $97.035B 0.00
GSK (GSK) United Kingdom $81.264B 9.43
Alnylam Pharmaceuticals (ALNY) United States $38.585B 0.00
Argenex SE (ARGX) Netherlands $32.326B 0.00
BioNTech SE (BNTX) Germany $27.995B 0.00
Biogen (BIIB) United States $27.530B 11.62
Illumina (ILMN) United States $22.922B 156.40
Moderna (MRNA) United States $22.087B 0.00
BeiGene (BGNE) Cayman Islands $21.625B 0.00
Genmab (GMAB) Denmark $14.956B 18.68
BioMarin Pharmaceutical (BMRN) United States $13.322B 39.42
Insmed (INSM) United States $13.172B 0.00
Vaxcyte (PCVX) United States $13.162B 0.00
Exact Sciences (EXAS) United States $13.048B 0.00
Incyte (INCY) United States $12.744B 827.12
Sarepta Therapeutics (SRPT) United States $12.009B 273.74
Bio-Techne Corp (TECH) United States $11.391B 44.60
QIAGEN (QGEN) Netherlands $9.861B 20.82
Bio-Rad Laboratories (BIO.B) United States $9.332B 30.92
Roivant Sciences (ROIV) United Kingdom $8.852B 0.00
Revolution Medicines (RVMD) United States $8.422B 0.00
Exelixis (EXEL) United States $8.372B 25.75
Intra-Cellular Therapies (ITCI) United States $8.040B 0.00
Legend Biotech (LEGN) United States $8.025B 0.00
Ascendis Pharma (ASND) Denmark $7.902B 0.00
Repligen (RGEN) United States $7.738B 118.09
Viking Therapeutics (VKTX) United States $7.296B 0.00
Nuvalent (NUVL) United States $6.791B 0.00
Halozyme Therapeutics (HALO) United States $6.772B 17.82
Cytokinetics (CYTK) United States $6.504B 0.00
Zealand Pharma (ZLDPF) Denmark $5.769B 0.00
Blueprint Medicines (BPMC) United States $5.659B 0.00
Avidity Biosciences (RNA) United States $5.374B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.318B 0.00
Krystal Biotech (KRYS) United States $5.108B 341.89
Arcellx (ACLX) United States $4.999B 0.00
Biohaven (BHVN) United States $4.866B 0.00
Alkermes (ALKS) Ireland $4.626B 16.24
Axsome Therapeutics (AXSM) United States $4.273B 0.00
Immunovant (IMVT) United States $4.270B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.167B 0.00
Denali Therapeutics (DNLI) United States $3.960B 0.00
ADMA Biologics Inc (ADMA) United States $3.832B 63.23
Merus (MRUS) Netherlands $3.567B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.453B 0.00
Apellis Pharmaceuticals (APLS) United States $3.403B 0.00
Edgewise Therapeutics (EWTX) United States $3.285B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.229B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.199B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.138B 0.00
Amicus Therapeutics (FOLD) United States $3.114B 0.00
Kymera Therapeutics (KYMR) United States $3.027B 0.00
Protagonist Therapeutics (PTGX) United States $2.768B 17.93
Verona Pharma American Depositary Share (VRNA) United Kingdom $2.764B 0.00
Neumora Therapeutics (NMRA) United States $2.669B 0.00
Guardant Health (GH) United States $2.660B 0.00
Twist Bioscience (TWST) United States $2.640B 0.00
Iovance Biotherapeutics (IOVA) United States $2.622B 0.00
IDEAYA Biosciences (IDYA) United States $2.619B 0.00
Zai Lab (ZLAB) China $2.607B 0.00
ImmunityBio (IBRX) United States $2.584B 0.00
Janux Therapeutics (JANX) United States $2.577B 0.00
Apogee Therapeutics (APGE) United States $2.556B 0.00
Geron (GERN) United States $2.514B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.495B 83.56
CG Oncology (CGON) United States $2.485B 0.00
Bavarian Nordic (BVNRY) Denmark $2.431B 13.01
Keros Therapeutics (KROS) United States $2.333B 0.00
Scholar Rock Holding (SRRK) United States $2.321B 0.00
Longboard Pharmaceuticals (LBPH) United States $2.311B 0.00
SpringWorks Therapeutics (SWTX) United States $2.237B 0.00
Structure Therapeutics (GPCR) United States $2.230B 0.00
Beam Therapeutics (BEAM) United States $2.200B 0.00
Vera Therapeutics (VERA) United States $2.193B 0.00
Myriad Genetics (MYGN) United States $2.172B 0.00
Akero Therapeutics (AKRO) United States $2.156B 0.00
Intellia Therapeutics (NTLA) United States $2.091B 0.00
Vericel (VCEL) United States $2.023B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.980B 17.87
Celldex Therapeutics (CLDX) United States $1.970B 0.00
Ligand Pharmaceuticals (LGND) United States $1.958B 33.28
Galapagos (GLPG) Belgium $1.949B 0.00
NovoCure (NVCR) Jersey $1.934B 0.00
Arvinas (ARVN) United States $1.908B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.898B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.875B 0.00
MannKind (MNKD) United States $1.851B 67.30
Nurix Therapeutics (NRIX) United States $1.828B 0.00
Certara (CERT) United States $1.805B 59.05
NeoGenomics (NEO) United States $1.772B 0.00
Fortrea Holdings (FTRE) United States $1.753B 54.36
Belite Bio (BLTE) United States $1.714B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.693B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.664B 0.00
Spyre Therapeutics (SYRE) United States $1.648B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.644B 0.00
Arcus Biosciences (RCUS) United States $1.633B 0.00
Novavax (NVAX) United States $1.625B 0.00
Viridian Therapeutics (VRDN) United States $1.520B 0.00
Dynavax Technologies (DVAX) United States $1.445B 100.27
Tarsus Pharmaceuticals (TARS) United States $1.430B 0.00
Disc Medicine (IRON) United States $1.427B 0.00
Kura Oncology (KURA) United States $1.400B 0.00
Travere Therapeutics (TVTX) United States $1.381B 0.00
Tyra Biosciences (TYRA) United States $1.368B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.317B 0.00
Praxis Precision Medicines (PRAX) United States $1.315B 0.00
Gyre Therapeutics (GYRE) United States $1.307B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.307B 0.00
ANI Pharmaceuticals (ANIP) United States $1.255B 17.05
Cogent Biosciences (COGT) United States $1.242B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.200B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.136B 0.00
Vir Biotechnology (VIR) United States $1.075B 0.00
Mesoblast (MESO) Australia $1.074B 0.00
Rapport Therapeutics (RAPP) United States $1.069B 0.00
CARGO Therapeutics (CRGX) United States $1.057B 0.00
Bicara Therapeutics (BCAX) United States $1.046B 0.00
Cullinan Therapeutics (CGEM) United States $1.021B 0.00
Applied Therapeutics (APLT) United States $1.010B 0.00
ArriVent BioPharma (AVBP) United States $0.999B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.982B 0.00
Zymeworks (ZYME) United States $0.959B 0.00
AnaptysBio (ANAB) United States $0.952B 0.00
Sana Biotechnology (SANA) United States $0.941B 0.00
Castle Biosciences (CSTL) United States $0.932B 0.00
Prothena (PRTA) Ireland $0.921B 0.00
Pliant Therapeutics (PLRX) United States $0.919B 0.00
Liquidia Technologies (LQDA) United States $0.893B 0.00
MiMedx (MDXG) United States $0.859B 24.38
89BIO (ETNB) United States $0.847B 0.00
IGM Biosciences (IGMS) United States $0.841B 0.00
BioAge Labs (BIOA) United States $0.826B 0.00
Dianthus Therapeutics (DNTH) United States $0.821B 0.00
Erasca (ERAS) United States $0.805B 0.00
Annexon (ANNX) United States $0.805B 0.00
Immatics (IMTX) Germany $0.800B 0.00
Arbutus Biopharma (ABUS) United States $0.793B 0.00
Replimune (REPL) United States $0.780B 0.00
Zenas BioPharma (ZBIO) United States $0.776B 0.00
AbCellera Biologics (ABCL) Canada $0.772B 0.00
MBX Biosciences (MBX) United States $0.771B 0.00
Pacira BioSciences (PCRX) United States $0.767B 7.26
Tango Therapeutics (TNGX) United States $0.765B 0.00
LENZ Therapeutics (LENZ) United States $0.749B 0.00
Immunome (IMNM) United States $0.741B 0.00
Adaptive Biotechnologies (ADPT) United States $0.708B 0.00
Cytek Biosciences (CTKB) United States $0.705B 0.00
Olema Pharmaceuticals (OLMA) United States $0.704B 0.00
Humacyte (HUMA) United States $0.693B 0.00
Mineralys Therapeutics (MLYS) United States $0.693B 0.00
Neurogene (NGNE) United States $0.692B 0.00
Stoke Therapeutics (STOK) United States $0.686B 0.00
Oric Pharmaceuticals (ORIC) United States $0.681B 0.00
Entrada Therapeutics (TRDA) United States $0.657B 5.97
Y-mAbs Therapeutics (YMAB) United States $0.656B 0.00
Astria Therapeutics (ATXS) United States $0.652B 0.00
Avid Bioservices (CDMO) United States $0.651B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Abivax SA (ABVX) France $0.641B 0.00
Nuvation Bio (NUVB) United States $0.641B 0.00
CureVac (CVAC) Germany $0.636B 0.00
ACELYRIN, INC (SLRN) United States $0.607B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.604B 0.00
CorMedix Inc (CRMD) United States $0.604B 0.00
Q32 Bio (QTTB) United States $0.603B 0.00
Allogene Therapeutics (ALLO) United States $0.596B 0.00
Pharming Group (PHAR) Netherlands $0.589B 0.00
Celcuity (CELC) United States $0.589B 0.00
Oculis Holding AG (OCS) Switzerland $0.578B 0.00
Third Harmonic Bio (THRD) United States $0.562B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.556B 0.00
Revance Therapeutics (RVNC) United States $0.553B 0.00
Terns Pharmaceuticals (TERN) United States $0.538B 0.00
REGENXBIO (RGNX) United States $0.531B 0.00
Alumis (ALMS) United States $0.528B 0.00
Tectonic Therapeutic (TECX) United States $0.522B 0.00
Aura Biosciences (AURA) United States $0.508B 0.00
Alector (ALEC) United States $0.506B 0.00
C4 Therapeutics (CCCC) United States $0.485B 0.00
Emergent Biosolutions (EBS) United States $0.485B 0.00
PureTech Health (PRTC) United States $0.482B 0.00
Prime Medicine (PRME) United States $0.475B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.474B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.470B 0.00
Absci (ABSI) United States $0.469B 0.00
Anavex Life Sciences (AVXL) United States $0.468B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.468B 0.00
Cartesian Therapeutics (RNAC) United States $0.468B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.460B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.460B 0.00
Foghorn Therapeutics (FHTX) United States $0.449B 0.00
GRAIL (GRAL) United States $0.445B 0.00
Voyager Therapeutics (VYGR) United States $0.431B 28.25
Contineum Therapeutics (CTNM) United States $0.426B 0.00
Biomea Fusion (BMEA) United States $0.417B 0.00
MaxCyte (MXCT) United States $0.405B 0.00
GH Research (GHRS) Ireland $0.403B 0.00
Northwest Biotherapeutics (NWBO) United States $0.392B 0.00
Alto Neuroscience (ANRO) United States $0.390B 0.00
MeiraGTx Holdings (MGTX) United States $0.384B 0.00
EnGene Holdings (ENGN) Canada $0.379B 0.00
Anika Therapeutics (ANIK) United States $0.373B 180.07
Nautilus Biotechnology (NAUT) United States $0.371B 0.00
Fate Therapeutics (FATE) United States $0.366B 0.00
ITeos Therapeutics (ITOS) United States $0.349B 0.00
XOMA Royalty (XOMA) United States $0.345B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.338B 0.00
Climb Bio (CLYM) United States $0.336B 0.00
Inozyme Pharma (INZY) United States $0.333B 0.00
Artiva Biotherapeutics (ARTV) United States $0.330B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.328B 0.00
Alpha Teknova (TKNO) United States $0.322B 0.00
Design Therapeutics (DSGN) United States $0.320B 0.00
Atea Pharmaceuticals (AVIR) United States $0.318B 0.00
AC Immune (ACIU) Switzerland $0.316B 0.00
UniQure (QURE) Netherlands $0.315B 0.00
GENFIT S.A (GNFT) France $0.314B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.311B 0.00
Sutro Biopharma (STRO) United States $0.309B 0.00
Nkarta (NKTX) United States $0.306B 0.00
Zura Bio (ZURA) United States $0.304B 0.00
Kamada (KMDA) Israel $0.302B 19.43
Prima BioMed (IMMP) Australia $0.297B 0.00
Opthea (OPT) Australia $0.297B 0.00
Urogen Pharma (URGN) United States $0.296B 0.00
PepGen (PEPG) United States $0.293B 0.00
TScan Therapeutics (TCRX) United States $0.292B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.286B 0.00
Editas Medicine (EDIT) United States $0.285B 0.00
Abeona Therapeutics (ABEO) United States $0.282B 0.00
Rezolute (RZLT) United States $0.277B 0.00
Jasper Therapeutics (JSPR) United States $0.275B 0.00
Compass Therapeutics (CMPX) United States $0.272B 0.00
Solid Biosciences (SLDB) United States $0.271B 0.00
Ocugen (OCGN) United States $0.270B 0.00
ChromaDex (CDXC) United States $0.270B 0.00
Instil Bio (TIL) United States $0.267B 0.00
Mersana Therapeutics (MRSN) United States $0.259B 0.00
2seventy Bio (TSVT) United States $0.257B 0.00
Codexis (CDXS) United States $0.250B 0.00
Poseida Therapeutics (PSTX) United States $0.247B 0.00
Kyverna Therapeutics (KYTX) United States $0.239B 0.00
Amarin (AMRN) Ireland $0.238B 0.00
XBiotech (XBIT) United States $0.235B 0.00
Inhibrx Biosciences (INBX) United States $0.232B 0.00
Trevi Therapeutics (TRVI) United States $0.232B 0.00
Precigen (PGEN) United States $0.229B 0.00
Cabaletta Bio (CABA) United States $0.228B 0.00
Fulcrum Therapeutics (FULC) United States $0.226B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.223B 0.00
ScPharmaceuticals (SCPH) United States $0.221B 0.00
Gossamer Bio (GOSS) United States $0.219B 0.00
BioStem Technologies (BSEM) $0.215B 33.81
Orchestra BioMed Holdings (OBIO) United States $0.214B 0.00
Eton Pharmaceuticals (ETON) United States $0.213B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.212B 0.00
Sangamo Therapeutics (SGMO) United States $0.207B 0.00
ATyr Pharma (ATYR) United States $0.206B 0.00
Candel Therapeutics (CADL) United States $0.200B 0.00
Black Diamond Therapeutics (BDTX) United States $0.192B 0.00
DiaMedica Therapeutics (DMAC) United States $0.188B 0.00
Caribou Biosciences (CRBU) United States $0.186B 0.00
Greenwich LifeSciences (GLSI) United States $0.184B 0.00
Molecular Partners AG (MOLN) Switzerland $0.182B 0.00
Ventyx Biosciences (VTYX) United States $0.182B 0.00
Semper Paratus Acquisition (TVGN) United States $0.177B 0.00
Adverum Biotechnologies (ADVM) United States $0.171B 0.00
Innate Pharma S.A (IPHA) France $0.170B 0.00
Sagimet Biosciences (SGMT) United States $0.167B 0.00
Scilex Holding (SCLX) United States $0.167B 0.00
Generation Bio (GBIO) United States $0.164B 0.00
Akoya Biosciences (AKYA) United States $0.158B 0.00
Kodiak Sciences (KOD) United States $0.158B 0.00
Actuate Therapeutics (ACTU) United States $0.158B 0.00
Vigil Neuroscience (VIGL) United States $0.153B 0.00
Compugen (CGEN) Israel $0.152B 0.00
Inovio Pharmaceuticals (INO) United States $0.149B 0.00
Renovaro (RENB) United States $0.146B 0.00
Repare Therapeutics (RPTX) Canada $0.145B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.144B 0.00
Seres Therapeutics (MCRB) United States $0.143B 0.00
Lifecore Biomedical (LFCR) United States $0.142B 0.00
Puma Biotechnology (PBYI) United States $0.141B 15.16
Rani Therapeutics Holdings (RANI) United States $0.139B 0.00
Immunic (IMUX) United States $0.139B 0.00
Tenaya Therapeutics (TNYA) United States $0.138B 0.00
Verastem (VSTM) United States $0.134B 0.00
23andMe Holding (ME) United States $0.131B 0.00
Cardiff Oncology (CRDF) United States $0.130B 0.00
Skye Bioscience (SKYE) United States $0.130B 0.00
Elutia (ELUT) United States $0.130B 0.00
Bright Minds Biosciences (DRUG) United States $0.128B 0.00
Adherex Technologies (FENC) United States $0.128B 116.25
Inventiva S.A (IVA) France $0.127B 0.00
Checkpoint Therapeutics (CKPT) United States $0.127B 0.00
Nuvectis Pharma (NVCT) United States $0.123B 0.00
Adicet Bio (ACET) United States $0.123B 0.00
Oncobiologics (OTLK) United States $0.123B 0.00
Seer (SEER) United States $0.122B 0.00
Coya Therapeutics (COYA) United States $0.122B 0.00
Annovis Bio (ANVS) United States $0.119B 0.00
Invivyd (IVVD) United States $0.118B 0.00
PDS Biotechnology (PDSB) United States $0.117B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.116B 0.00
FibroBiologics (FBLG) United States $0.114B 0.00
I-Mab (IMAB) China $0.110B 0.00
Genelux (GNLX) United States $0.107B 0.00
Genenta Science S.p.A (GNTA) Italy $0.107B 0.00
Adagene (ADAG) China $0.106B 0.00
Cellectis S.A (CLLS) France $0.106B 0.00
Benitec Biopharma (BNTC) United States $0.104B 0.00
INmune Bio (INMB) United States $0.103B 0.00
Coherus BioSciences (CHRS) United States $0.102B 0.00
Agenus (AGEN) United States $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.098B 0.00
Oncolytics Biotech (ONCY) Canada $0.096B 0.00
BioAtla (BCAB) United States $0.095B 0.00
Bluebird Bio (BLUE) United States $0.093B 0.00
BeyondSpring (BYSI) United States $0.093B 0.00
CytomX Therapeutics (CTMX) United States $0.092B 8.43
MediciNova (MNOV) United States $0.091B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.091B 0.00
HilleVax (HLVX) United States $0.091B 0.00
Werewolf Therapeutics (HOWL) United States $0.090B 0.00
X4 Pharmaceuticals (XFOR) United States $0.090B 0.00
InflaRx (IFRX) Germany $0.089B 0.00
CervoMed (CRVO) United States $0.087B 0.00
BioHarvest Sciences (CNVCF) Canada $0.086B 0.00
Ovid Therapeutics (OVID) United States $0.084B 0.00
Clearside Biomedical (CLSD) United States $0.084B 0.00
Ikena Oncology (IKNA) United States $0.083B 0.00
ALX Oncology Holdings (ALXO) United States $0.082B 0.00
VistaGen Therapeutics (VTGN) United States $0.082B 0.00
Galena Biopharma (SLS) United States $0.080B 0.00
Aileron Therapeutics (ALRN) United States $0.080B 0.00
IO Biotech (IOBT) Denmark $0.078B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.078B 0.00
Chimerix (CMRX) United States $0.078B 0.00
Cidara Therapeutics (CDTX) United States $0.076B 0.00
Adlai Nortye (ANL) Cayman Islands $0.072B 0.00
ZIVO Bioscience (ZIVO) United States $0.072B 0.00
Shattuck Labs (STTK) United States $0.069B 0.00
Connect Biopharma Holdings (CNTB) United States $0.069B 0.00
Aerovate Therapeutics (AVTE) United States $0.068B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.068B 0.00
Boundless Bio (BOLD) United States $0.068B 0.00
DBV Technologies S.A (DBVT) France $0.068B 0.00
Spero Therapeutics (SPRO) United States $0.067B 3.02
Immuneering (IMRX) United States $0.066B 0.00
Entera Bio (ENTX) Israel $0.065B 0.00
Kezar Life Sciences (KZR) United States $0.065B 0.00
Precision BioSciences (DTIL) United States $0.065B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.065B 0.00
TELA Bio (TELA) United States $0.064B 0.00
Leap Therapeutics (LPTX) United States $0.061B 0.00
Celularity (CELU) United States $0.061B 0.00
Rapt Therapeutics (RAPT) United States $0.061B 0.00
Imunon (IMNN) United States $0.060B 0.00
Theratechnologies (THTX) Canada $0.059B 0.00
Allakos (ALLK) United States $0.059B 0.00
Kronos Bio (KRON) United States $0.058B 0.00
Enzo Biochem (ENZ) United States $0.058B 0.00
Aadi Bioscience (AADI) United States $0.053B 0.00
Cue Biopharma (CUE) United States $0.052B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.052B 0.00
Syros Pharmaceuticals (SYRS) United States $0.051B 0.00
Elicio Therapeutics (ELTX) United States $0.051B 0.00
Affimed (AFMD) Germany $0.051B 0.00
Omega Therapeutics (OMGA) United States $0.050B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.049B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.047B 0.00
HOOKIPA Pharma (HOOK) United States $0.047B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.047B 0.00
Vor Biopharma (VOR) $0.046B 0.00
Intensity Therapeutics (INTS) United States $0.045B 0.00
Rallybio (RLYB) United States $0.045B 0.00
Lexaria Bioscience (LEXX) Canada $0.045B 0.00
Atara Biotherapeutics (ATRA) United States $0.045B 0.00
CalciMedica (CALC) United States $0.045B 0.00
VTv Therapeutics (VTVT) United States $0.043B 0.00
NextCure (NXTC) United States $0.041B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.041B 0.00
Fortress Biotech (FBIO) United States $0.040B 0.00
Immix Biopharma (IMMX) United States $0.040B 0.00
Equillium (EQ) United States $0.039B 0.00
Clene (CLNN) United States $0.039B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
Passage Bio (PASG) United States $0.037B 0.00
OKYO Pharma (OKYO) $0.036B 0.00
Quince Therapeutics (QNCX) United States $0.035B 0.00
Eyenovia (EYEN) United States $0.035B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
LakeShore Biopharma (LSB) China $0.034B 0.00
Ocean Biomedical (OCEA) United States $0.034B 0.00
Dyadic (DYAI) United States $0.034B 0.00
Ocuphire Pharma (OCUP) United States $0.034B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.033B 0.00
Elevation Oncology (ELEV) United States $0.033B 0.00
Lumos Pharma (LUMO) United States $0.033B 0.00
Curis (CRIS) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.031B 0.00
Promis Neurosciences (PMN) Canada $0.031B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.031B 0.00
Dare Bioscience (DARE) United States $0.031B 0.00
BRIACELL THERAP (BCTX) Canada $0.030B 0.00
BioAffinity Technologies (BIAF) United States $0.029B 0.00
Longeveron (LGVN) United States $0.029B 0.00
SAB Biotherapeutics (SABS) United States $0.029B 0.00
Bionano Genomics (BNGO) United States $0.029B 0.00
Femasys (FEMY) United States $0.027B 0.00
MiNK Therapeutics (INKT) United States $0.027B 0.00
Pluri (PLUR) Israel $0.027B 0.00
Bolt Biotherapeutics (BOLT) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
RenovoRx (RNXT) United States $0.024B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.024B 0.00
KALA BIO (KALA) United States $0.024B 0.00
UNITY Biotechnology (UBX) United States $0.024B 0.00
BioXcel Therapeutics (BTAI) United States $0.024B 0.00
Aligos Therapeutics (ALGS) United States $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
HCW Biologics (HCWB) United States $0.023B 0.00
Cyclo Therapeutics (CYTH) United States $0.023B 0.00
Cocrystal Pharma (COCP) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
Biora Therapeutics (BIOR) United States $0.022B 0.00
Spruce Biosciences (SPRB) United States $0.021B 0.00
Aprea Therapeutics (APRE) United States $0.019B 0.00
Monopar Therapeutics (MNPR) United States $0.019B 0.00
Chemomab Therapeutics (CMMB) Israel $0.018B 0.00
Cognition Therapeutics (CGTX) United States $0.018B 0.00
GeoVax Labs (GOVX) United States $0.018B 0.00
Athira Pharma (ATHA) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Cadrenal Therapeutics (CVKD) United States $0.016B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.016B 0.00
Orgenesis (ORGS) United States $0.016B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Evaxion Biotech (EVAX) Denmark $0.015B 0.00
Cara Therapeutics (CARA) United States $0.015B 0.00
Aytu BioPharma (AYTU) United States $0.014B 0.00
COSCIENS Biopharma (CSCI) Canada $0.014B 0.00
Cingulate (CING) United States $0.013B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.013B 0.00
Edesa Biotech (EDSA) Canada $0.013B 0.00
Carmell (CTCX) United States $0.013B 0.00
Tenax Therapeutics (TENX) United States $0.013B 0.00
Kintara Therapeutics (KTRA) United States $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Vincerx Pharma (VINC) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Apollomics (APLM) United States $0.011B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
IN8bio (INAB) United States $0.011B 0.00
Evogene (EVGN) Israel $0.011B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
NKGen Biotech (NKGN) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Novogen (KZIA) Australia $0.009B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
TFF Pharmaceuticals (TFFP) United States $0.007B 0.00
Organovo Holdings (ONVO) United States $0.007B 0.00
Gritstone Bio (GRTS) United States $0.007B 0.00
Portage Biotech (PRTG) $0.007B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Forte Biosciences (FBRX) United States $0.007B 0.00
180 Life Sciences (ATNF) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Eterna Therapeutics (ERNA) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
BioCardia (BCDA) United States $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.005B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.00
Dogwood Therapeutics (DWTX) United States $0.005B 0.00
NuCana (NCNA) United Kingdom $0.005B 0.00
AquaBounty Technologies (AQB) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Vaccinex (VCNX) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Biofrontera (BFRI) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Invo BioScience (INVO) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Bionomics (BNOX) Australia $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Elevai Labs (ELAB) United States $0.002B 0.00
Ensysce Biosciences (ENSC) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
GENPREX (GNPX) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00